Simultaneous inhibition of Src and Aurora kinases by SU6656 induces therapeutic synergy in human synovial sarcoma growth, invasion and angiogenesis in vivo-Reference-Cited by-同舟云学术

Simultaneous inhibition of Src and Aurora kinases by SU6656 induces therapeutic synergy in human synovial sarcoma growth, invasion and angiogenesis in vivo

Published:2012-10 Issue:15 Volume:48 Page:2417-2430
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Arai Ryuta,Tsuda Masumi,Watanabe Takuya,Ose Toyoyuki,Obuse Chikashi,Maenaka Katsumi,Minami Akio,Ohba Yusuke

Funder

Ministry of Education, Culture, Sports, Science, and Technology

Ministry of Health, Labour and Welfare of Japan

Japan Science and Technology Agency

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference44 articles.

1. Synovial sarcoma;Fisher;Ann Diagn Pathol,1998

2. Synovial sarcoma: identification of low and high risk groups;Bergh;Cancer,1999

3. Synovial sarcoma: prognostic significance of tumor size, margin of resection, and mitotic activity for survival;Singer;J Clin Oncol,1996

4. Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment;Spillane;J Clin Oncol,2000

5. Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital;Spurrell;Ann Oncol,2005

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aurora kinase B disruption suppresses pathological retinal angiogenesis by affecting cell cycle progression;Experimental Eye Research;2024-02

2. Src family kinase targeting in head and neck tumor cells using SU6656 , PP2 and dasatinib;Head & Neck;2022-10-25

3. Synthesis, biological evaluation and molecular docking of new sulfonamide-based indolinone derivatives as multitargeted kinase inhibitors against leukemia;Bioorganic Chemistry;2021-12

4. Recent researches for dual Aurora target inhibitors in antitumor field;European Journal of Medicinal Chemistry;2020-10

5. The Role of Shcbp1 in Signaling and Disease;Current Cancer Drug Targets;2019-12-23